Palisade Bio, Inc. (NASDAQ:PALI) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Catherine Angell Sohn Other companies: Maze Therapeutics, Inc. (Director · Since at least Jan 30, 2025); Altimmune, Inc. (Director · Since at least Mar 23, 2023); Axcella Health Inc (Director · Aug 21, 2019 – May 19, 2022 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – May 12, 2022 · Past); Lifecore Biomedical, Inc. (Director · Nov 13, 2012 – Jun 4, 2022 · Past); Jazz Pharmaceuticals plc (Director · Jul 27, 2012 – Aug 11, 2023 · Past) | Director · Jan 13, 2014 – Jul 1, 2015 · Past |
| Mary Ann Gray Other companies: BioAtla, Inc. (Director · Since at least Jun 16, 2022); Keros Therapeutics, Inc. (Director · Since at least Jun 1, 2022); Compass Therapeutics, Inc. (Director · Since at least Apr 26, 2022); RAPT Therapeutics Inc (Director · Since at least Mar 31, 2022) | Director · Jun 11, 2023 – Nov 21, 2023 · Past |
| Robert Baltera Jr Other companies: Imago Biosciences Inc (Director · Jul 15, 2021 – Jan 11, 2023 · Past); Frazier Lifesciences Acquisition Corp (Director · Dec 8, 2020 – Nov 22, 2022 · Past); Xencor, Inc. (Director · Dec 2, 2013 – Jun 23, 2016 · Past); VivoSim Labs, Inc. (Director · Mar 13, 2012 – Jul 26, 2018 · Past) | Director · Since at least Jun 10, 2026 |
| James R. Neal Other companies: Akari Therapeutics PLC (Director · Since at least Nov 14, 2024); Processa Pharmaceuticals, Inc. (Director · Since at least Jul 19, 2022); Monterey Bio Acquisition Corp (Director · Sep 30, 2021 – Sep 30, 2021 · Past) | Director · Apr 27, 2021 – Feb 9, 2024 · Past |
| Donald A. Williams Other companies: Akari Therapeutics PLC (Director · Jan 1, 2024 – Jun 28, 2024 · Past) | Director · Since at least Jun 10, 2026 |
| Jones Jonathan Brian Lloyd Other companies: Juniper Pharmaceuticals Inc (Vice President & CFO · Jan 15, 2013 – May 5, 2014 · Past) | Chief Financial Officer · May 18, 2015 – Mar 24, 2017 · Past |
| William Clyde Oldaker Other companies: WashingtonFirst Bankshares Inc (Director · Jan 1, 2018 – Jan 1, 2018 · Past) | Director · Jul 2, 2018 – Jul 1, 2019 · Past |
| Adarsh Patel | Head of Chemistry, Manufacturing and Controls (CMC) · Since at least Nov 4, 2026 |
| Binxian Wei | Director · Since at least Jun 10, 2026 |
| Daniel J. Larkins | Head of Global Regulatory Affairs · Since at least Nov 4, 2026 |
| Dawn Louro | Head of Clinical Operations · Since at least Nov 4, 2026 |
| Emil Chuang | Director · Since at least Jul 7, 2025 |
| James Izanec | Head of Clinical Development · Since at least Sep 28, 2026 |
| JD Finley | Chief Executive Officer and Director · Since at least Oct 28, 2026 |
| Joerg Heyer | Head of Translational Science and Medicine · Since at least May 1, 2025 |
| John David Finley | CEO CFO, Director · Since at least Apr 29, 2022 |
| Jordan Zwick | Director · Since at least Jun 10, 2026 |
| Julien E. Capers | See Remarks · Since at least Oct 19, 2026 |
| Kenneth C Carter | Executive Chairman, Director · Dec 12, 2018 – Dec 12, 2018 · Past |
| Michael John Dawson | Chief Medical Officer · Apr 27, 2021 – Mar 29, 2022 · Past |
| Mitchell Lawrence Jones | See Remarks · Since at least Sep 4, 2025 |
| Mitch Jones | President and Chief Medical Officer · Since at least Oct 28, 2026 |
| Ramesh Donthamsetty | Head of IR and Corporate Strategy · Since at least Nov 4, 2026 |
| Robert Baltera | Director · Since at least Jul 10, 2026 |
| Robert J Trenschel | Director · Apr 27, 2021 – Feb 8, 2024 · Past |
| Ryker Willie | Head of Finance and Corporate Controller · Since at least Nov 4, 2026 |
| Stephanie Diaz | Director · Apr 27, 2021 – Feb 8, 2024 · Past |